Guggenheim on Feb 04, 2026 maintained a Neutral view on NYT and raised its price target to $63, giving the clearest NYT analyst rating update this week. The action listed at 12:55 PM reflects a measured stance, with the firm keeping its rating unchanged while boosting the target. Investors should note the firm cited valuation upside but retained caution on advertising cycles. This NYT analyst rating ties directly to recent stock movement and helps frame short to medium term expectations.
NYT analyst rating overview
Guggenheim maintained a Neutral rating on NYT on Feb 04, 2026 and raised its price target to $63. This entry is recorded in StreetInsider coverage and shows a mixed view of growth and valuation for The New York Times Company source.
Guggenheim action and price target details
Guggenheim’s note was logged at 12:55 PM and lists the price target increase as the main change. The firm left the rating as Neutral while lifting the PT to $63, citing better-than-expected subscription trends and cautious ad recovery assumptions. The bulletin shows a 6.96% ($4.7) move since the prior target reference.
What the NYT analyst rating means for investors
A maintained Neutral with a higher target signals modest upside without a clear buy case. Investors should view this NYT analyst rating as a pause signal, not an endorsement to add aggressively. The raised PT suggests improved fundamentals, but the Neutral rating keeps risk controls in place for portfolio managers.
Historical analyst coverage of NYT
Analyst coverage of The New York Times Company has mixed ratings over recent years, ranging from Buy to Hold. Guggenheim’s maintained Neutral fits a longer pattern of cautious optimism, where price target changes often reflect subscription momentum. Market consensus has shifted with earnings beats and ad trends, making each shop’s target revisions meaningful to traders and holders.
Market and stock reaction to the NYT analyst rating
The market cap stands at $11,014,692,970 and price moves often follow PT changes. Guggenheim’s raised PT and Neutral rating typically produce short-term trading volume and measured price moves. Investors watching momentum should link the NYT analyst rating to near-term volatility and to earnings or ad-cycle catalysts for confirmation.
Meyka analysis and Meyka grade for NYT
Meyka AI rates NYT with a grade of B+. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Our view treats Guggenheim’s maintained Neutral and raised PT as a signal of moderate upside, and we note this grade is not a recommendation. Meyka’s AI-powered market analysis platform tracks these changes in real time for investors.
Final Thoughts
Guggenheim’s maintained Neutral on NYT on Feb 04, 2026, with a raised price target of $63, gives investors a balanced update. The NYT analyst rating shows that analysts see subscription strength but remain cautious on advertising recovery. For holders, the maintained Neutral suggests holding while monitoring ad revenue and subscriber growth. For potential buyers, the raised PT points to upside, but the Neutral rating advises staged entries or hedging. The market cap of $11,014,692,970 and the 6.96% ($4.7) note underscore measurable market response. Meyka AI rates NYT with a grade of B+, reflecting relative strength versus peers and solid fundamentals. Use this NYT analyst rating update with your risk plan and watch upcoming earnings and ad data for clearer signals.
FAQs
What exactly changed in the Guggenheim note on Feb 04, 2026?
Guggenheim maintained a Neutral rating for NYT and raised its price target to $63. The note was issued at 12:55 PM and cited subscription resilience and cautious ad trends as drivers for the PT increase.
How should I interpret the NYT analyst rating for my portfolio?
A maintained Neutral in the NYT analyst rating means moderate conviction. It suggests monitoring key metrics rather than making large buys. Consider staged positions and watch ad revenue and subscriber growth for clearer direction.
Does the price target change alter NYT’s outlook?
A higher NYT price target improves the implied upside but does not change conviction when the rating stays Neutral. The PT to $63 signals better fundamentals but keeps caution on cyclical ad recovery.
What is Meyka’s view on NYT after this rating change?
Meyka AI rates NYT with a grade of B+. We see the Guggenheim action as modestly positive, but still favor watching earnings and ad data for confirmation before increasing exposure.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Analyst ratings are opinions and not guarantees of future performance. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
